Tacrolimus Toxicities in clinical practice- A Case based perspective

Author(s)	Dr. Riona Mathew, Dr. Ranimol Mathew, Dr. Harikrishnan S, Dr. Jacob Jeshurun
Country	India
Abstract	Tacrolimus is a calcineurin inhibitor used as an immunosuppressant and is used in various conditions like prevention of organ transplant rejection, atopic dermatitis and psoriasis. In our set of series we are mainly focusing on toxicities like AKI (acute kidney injury), thrombotic microangiopathy, acute pancreatitis, hypomagnesemia and PRES(Posterior reversible encephalopathy) and hyperkalemia which are some of the major reactions and needs quick intervention. Even though most of the reactions are preventable they should be timely detected and stopped if not may also be fatal. Even though tacrolimus is crucial and cannot be avoided it would be better if given in reduced doses and also avoid longer duration of treatment. Hence monitoring of tacrolimus induced adverse drug reactions may help in getting a picture on avoiding it and help increase patient efficacy and adherence during treatment.
Keywords	AKI (Acute Kidney Injury), PRES (Posterior reversible encephalopathy) ADR (Adverse drug reactions).
Field	Biology > Medical / Physiology
Published In	Volume 7, Issue 4, July-August 2025
Published On	2025-08-10
DOI	https://doi.org/10.36948/ijfmr.2025.v07i04.53424
Short DOI	https://doi.org/g9w5cc

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9687-828-838	editor@ijfmr.com

International Journal For Multidisciplinary Research